When to try a flapless submucosal approach — and when to go to surgery: practical takeaways from three new Periodontology 2000 reviews

Minimally invasive, flapless submucosal instrumentation can stop disease in selected peri-implantitis cases, but predictable long-term control still depends on defect anatomy, soft‑tissue phenotype and a clear stepwise pathway to surgical reconstruction when needed.

Three new narrative reviews in Periodontology 2000 review current evidence on a less‑invasive ‘flapless submucosal instrumentation’ pathway, the patient‑ and site‑level factors that influence surgical outcomes, and the value of soft‑tissue grafting in preventing and managing peri‑implantitis. Together they give a practical, evidence‑informed framework for deciding what you should try in your chair this week. ([onlinelibrary.wiley.com](

What the flapless approach is and when it may work: flapless submucosal instrumentation means removing peri‑implant granulation tissue and biofilm through a minimally invasive mucosal access (no full flap elevation), with mechanical debridement and local antisepsis. The reviews present it as a step in a graded care pathway for selected, treatable lesions where bone loss is limited, the prosthesis can be managed, and patient factors are favourable. Observational reports and small series show that disease resolution is achievable in a meaningful minority of implants (roughly 44–54% in some cohorts), but results are variable and case selection is essential. ([pubmed.ncbi.nlm.nih.gov](

What the randomized and comparative evidence says: a multicentre randomized trial that tested pre‑surgical sub‑marginal instrumentation found no added benefit from an earlier, separate non‑surgical phase in terms of one‑year treatment success or additional pocket depth reduction — in other words, simply doing more pre‑surgical debridement did not reliably convert cases that needed surgery into cases that did not. That supports using flapless submucosal techniques selectively rather than as a universal 'try first' for moderate‑to‑advanced defects. ([onlinelibrary.wiley.com](

Which factors change the odds of success: the surgical outcomes review emphasises that defect morphology (depth, intrabony component and defect angle), implant position and surface, the remaining soft‑tissue phenotype (keratinized width and thickness), and patient risks (history of periodontitis, smoking, systemic disease, and plaque control) all materially affect success and recurrence. In plain terms: the deeper the bony defect and the thinner/absent the keratinized mucosa, the less likely a simple, flapless approach will give durable disease control and the more likely staged surgical reconstruction with regenerative materials or resective access will be needed. ([eurekamag.com](

Where soft‑tissue grafting fits in: the soft‑tissue review and longitudinal meta-analyses of keratinized mucosa show that implants with little or no keratinized tissue are at higher risk of peri‑implant disease, and that grafting to increase keratinized width and soft‑tissue thickness can help stabilise outcomes after surgery. Practically, consider soft‑tissue augmentation when keratinized width is deficient (<~2 mm) or when thin tissue predisposes to recession after debridement. The evidence base is improving but still heterogeneous; grafting is an adjunct, not a guaranteed cure. ([pmc.ncbi.nlm.nih.gov](

A simple, clinic‑ready decision pathway for Monday morning: step 1 — triage with clinical probing and a periapical/CBCT check of defect depth and extent; step 2 — if bone loss is shallow, prosthesis manageable and patient risk low, you may attempt flapless submucosal instrumentation (remove prosthesis if it blocks access, debride with curettes/ultrasonic tips, irrigate and re‑evaluate at 6–12 weeks); step 3 — if pockets persist, defects are intrabony/deep, or the soft‑tissue phenotype is poor, plan an open surgical approach with defect‑specific strategy and consider simultaneous or staged soft‑tissue grafting; step 4 — document, photograph, and follow a strict maintenance schedule. Implant collar design and emergence profile affect how easily you can reach the contaminated surface (this matters for many systems, including TISS implants). ([onlinelibrary.wiley.com](

Limitations and what to tell patients: the three reviews are honest — the overall evidence strength is mixed, many studies are small or retrospective, and long‑term comparative data are scarce. Tell patients that a flapless attempt may avoid more invasive surgery in selected cases, but it is not a reliable definitive treatment for moderate‑to‑severe defects; explain the possibility of staged surgery and the need for strict maintenance. ([onlinelibrary.wiley.com](